Interview by Dr Neil Love recorded on April 17, 2026. Published July 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 1.25 credits
MOC types
ABS — Accredited CMEUp to 1.25 pointsABIM — Medical KnowledgeUp to 1.25 pointsABS — Self-AssessmentUp to 1.25 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 2 South Biscayne Blvd
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1.25 credits
- MOC · Up to 1.25 points
-
ReleasedAug 1, 2026
-
Last day to claim creditAug 3, 2027 10 months left
-
Research to Practice Data + Perspectives: The Potential Role of TROP2- and CDH6-Directed Antibody-Drug Conjugates in Gynecologic Cancers | 2026 (Symposium Proceedings)
-
Research to Practice Oncology Today with Dr Neil Love: Optimizing the Use of Antibody-Drug Conjugates for Multiple Myeloma | 2026 (Interview)
-
Research to Practice Oncology Today with Dr Neil Love: Novel Investigational Antibody-Drug Conjugates for Ovarian Cancer | 2026 (Video Lecture)
-
PRIME Education, Inc. (PRIME®) Unpacking Trop-2: Mechanisms of Action and Therapeutic Rationale for Trop-2-Targeted Therapies in Breast Cancer
-
Global Learning Collaborative Chairman’s Perspective: TROP2-Targeted ADCs in TNBC and HR+ mBC
-
Efficient CME, CME Outfitters, LLC Addressing Unmet Needs in Non-Small Cell Lung Cancer: The Evolving Role of TROP2-Directed Therapies
